Practice Guideline for the Management of Ductal Carcinoma In-Situ of the Breast (DCIS)

Journal of the American College of Surgeons

Volumn 205, Issue 1, 2007, Pages

  American College of Radiology, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER RADIOTHERAPY; CARCINOMA IN SITU; HUMAN; MAMMOGRAPHY; MASTECTOMY; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; UNITED STATES;

EID: 34347342825     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.02.056     Document Type: Article

References (129)

1. Dershaw D.D., Abramson A., and Kinne D.W. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 170 (1989) 411-415
2. Stomper P.C., Connolly J.L., Meyer J.E., et al. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiographic-pathologic correlation. Radiology 172 (1989) 235-241
3. Sigfusson I., Aspergren K., Janzon L., et al. Clustered breast calcifications. Acta Radiol (Diagn) (Stockh) 24 (1983) 273-281
4. Ikeda D.M., and Anderson I. Ductal carcinoma in situ: atypical mammographic appearances. Radiology 172 (1989) 661-666
5. Holland R., Hendricks J.H., Verbeek A.L.M., et al. Clinical practice: extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335 (1990) 519-522
6. Sickles E.A. Further experience with microfocal spot magnification mammography in the assessment of clustered breast microcalcifications. Radiology 137 (1980) 9-14
7. Sickles E.A. Mammographic detectability of breast microcalcifications. AJR 139 (1982) 913-918
8. Sickles E.A. Breast calcifications: mammographic evaluation. Radiology 160 (1986) 289-293
9. Ringberg A., Palmer B., and Linell F. The contralateral breast at reconstructive surgery after breast cancer operation: a histiopathological study. Breast Cancer Res Treatment 2 (1982) 151-161
10. Gilles R., Zafrani B., Guinebretiere J.M., et al. Ductal carcinoma in situ: MR imaging-histiopathologic correlation. Radiology 196 (1995) 415-419
11. Orel S.G., Mendonca M.H., Reynolds C., et al. MR imaging of ductal carcinoma in situ. Radiology 202 (1997) 413-420
12. Stomper P.C., Herman S., Klippenstein D.L., et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197 (1995) 387
13. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 (1999) 1-10
14. Daniel B.L., Yen Y.F., Glover G.H., et al. Breast disease: dynamic spiral MR imaging. Radiology 209 (1998) 499-509
15. Liberman L. Ductal carcinoma in situ: percutaneous biopsy considerations. Seminars in Breast Disease 3 (2000) 14-25
16. Stomper P.C., Winston J.S., Proulx G.M., et al. Mammographic detection and staging of ductal carcinoma in situ: mammographic-pathologic correlation. Seminars in Breast Disease 3 (2000) 26-41
17. Tabar L., Gad A., Parsons W.C., et al. Mammographic appearances of in situ carcinomas. In: Silverstein J.R. (Ed). Ductal Carcinoma in-situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 95-117
18. Holland R., Hendricks J.H., Verbeek A.L., et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335 (1990) 519-522
19. Holland R., and Hendricks J. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 11 (1994) 181-192
20. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
21. Berg W.A., Butierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
22. Moon W.K., Myung J.S., Lee Y.J., et al. RadioGraphics 22 (2002) 269-281
23. Melotti M.K., and Berg W.A. Core needle breast biopsy in patients undergoing anticoagulation therapy: preliminary results. AJR 174 (2000) 245-249
24. Jackman R.L., Nowels K.W., Shepard M.J., et al. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 193 (1994) 91-95
25. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 202 (1997) 843-847
26. Liberman L., LaTrenta L.R., Dershaw D.D., et al. Impact of core biopsy on the surgical management of impalpable breast cancer. Am J Roentgenol 168 (1997) 495-499
27. Morrow M., Venta L.A., Stinson T., et al. A prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 233 (2001) 537-541
28. Kinne D.W., Petrek J.A., Osborne M.P., et al. Breast carcinoma in situ. Arch Surg 124 (1989) 33-36
29. Silverstein M.J., Waisman J.R., Gamagami P., et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 66 (1990) 102-108
30. Pendas S., Dauway E., Guiliano R., et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7 (2000) 15-20
31. Yiangou C., Shousha S., and Sinnett H.D. Primary tumor characteristics and axillary lymph node status in breast cancer. Br J Cancer 90 (1999) 1974-1978
32. Pendas S., Jakub J., Giuliano R., et al. The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control 11 (2004) 231-235
33. Mittendorf M.E., Arciero C.A., Gutchell V., et al. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62 (2005) 253-257
34. Yen T.X., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 (2005) 516-526
35. Cody III H.S., Fey J., Akhurst T., et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 8 (2001) 13-19
36. 99mTc-labeled sulfur colloid. Ann Surg Oncol 8 (2001) 821-827
37. Albo D., Wayne J.D., Hunt K.K., et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 182 (2001) 393-398
38. Montgomery L.L., Thorne A.C., Van Zee K.J., et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 5 (2002) 385-388
39. Babiera G.V., Delpassand E.S., Breslin T.M., et al. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 30 (2005) 11-15
40. Hill A.D.K., Tran K.N., Akhurst T., et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 229 (1999) 528-535
41. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual. 6th edition (2002), Springer, New York, NY
42. Schnitt S.J., and Connolly J.L. Processing and evaluation of breast excision specimens: a clinically oriented approach. Am J Clin Pathol 98 (1992) 125-137
43. Fitzgibbons P.L., Connolly J.L., and Page D.L. Updated protocol for the examination of specimens from patients with carcinomas of the breast. Arch Pathol Lab Med 124 (2000) 1026-1033
44. Association of Directors of Anatomic and Surgical Pathology. Immediate management of mammographically detected breast lesions. Am J Surg Pathol 17 (1993) 850-851
45. Holland R., Peterse J.L., Millis R.R., et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 11 (1994) 167-180
46. Lagios M.D., Margolin F., Westdahl P.R., et al. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63 (1989) 618-624
47. Scott M.A., Lagios M.D., Axelsson K., et al. Ductal carcinoma in situ of the breast: reproducibility of histologic subtype analysis. (see comments). Hum Pathol 28 (1997) 967-973
48. Poller D.N., Silverstein M.J., Galea M., et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 7 (1994) 257-262
49. Silverstein M.J., Poller D.N., Waisman J.R., et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 345 (1995) 1154-1157
50. Ottesen G.L., Graversen H.P., Blichert-Toft M., et al. Ductal carcinoma in situ of the female breast: short-term results of a prospective nationwide study. Am J Surg Pathol 16 (1992) 1183-1196
51. Lagios M.D. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 70 (1990) 853-871
52. Badve S., A'Hern R.P., Ward A.M., et al. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol 29 (1998) 915-923
53. Patchefsky A.S., Schwartz G.F., Finkelstein S.D., et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 63 (1989) 731-741
54. Bellamy C.O., McDonald C., Salter D.M., et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 24 (1993) 16-23
55. The Consensus Conference Committe. Consensus conference of the classification of ductal carcinoma in situ. Cancer 80 (1997) 1798-1802
56. Douglas-Jones A.G., Gupta S.K., Attanoos R.L., et al. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive cancer. Histopathology 29 (1996) 397-409
57. Bethwaite P., Smith N., Delahunt B., et al. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast. J Clin Pathol 51 (1998) 450-454
58. Wells W.A., Carney P.A., Eliassen M.S., et al. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma in-situ classification schemes. Hum Pathol 24 (2000) 651-659
59. Sneige N., Lagios M.D., Schwarting R., et al. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol 30 (1999) 257-262
60. Fisher B., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 353 (1999) 1993-2000
61. Allred D.C., Bryant J., and Land S. Estrogen receptor expression as a predictive marker of effectiveness of tamoxifen in the treatment of DCIS; findings from NSABP protocol B24. Breast Ca Res Treat 76 (2002) S36
62. Fisher B., Costantino J., Redmond C., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328 (1993) 1581-1586
63. Fisher E.R., Costantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 75 (1995) 1310-1319
64. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28 (2001) 400-418
65. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86 (1999) 429-438
66. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B17. J Clin Oncol 16 (1998) 441-452
67. UK Coordinating Committee on Cancer Research Ductal Carcinoma in Situ Working Party. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet 362 (2003) 95
68. Julien J.P., Bijker N., Fentiman I.S., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet 355 (2000) 528-533
69. Solin L.J., Recht A., Fourquet A., et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 68 (1991) 2337-2344
70. Solin L.J., Kurtz J., Fourquet A., et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ (intraductal carcinoma of the breast). J Clin Oncol 14 (1996) 754-763
71. Solin L.J., Fourquet A., Vicini F.A., et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103 (2005) 1137-1146
72. Katz S.J., Lantz P.M., Janz N.K., et al. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol 23 (2005) 3001-3007
73. McCormick B., Rosen P.P., Kinne D., et al. Duct carcinoma in situ of the breast: an analysis of local control after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 21 (1991) 289-292
74. Sneige N., McNeese M.D., Atkinson E.N., et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 26 (1995) 642-649
75. Van Zee K.J., Liberman L., Samli B., et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer 86 (1999) 1757-1767
76. Solin L.J., McCormick B., Recht A., et al. Mammographically detected clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am 2 (1996) 158-165
77. Fowble B., Hanlon A.L., Fein D.A., et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ. Abstract Int J Radiat Oncol Biol Phys 36 (1996) 213
78. Bijker N., Peterse J.L., Duchateau L., et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19 (2001) 2263-2271
79. Kestin L.L., Goldstein N.S., Martinez A.A., et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Ann Surg 231 (2000) 235-245
80. Kuske R.R., Bean J.M., Garcia D.M., et al. Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 26 (1993) 391-396
81. Hiramatsu H., Bornstein B.A., Recht A., et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: possible importance of family history. Cancer J Sci Am 1 (1995) 55-61
82. Haffty B.G., Peschel R.E., Papdopoulus D., et al. Radiation therapy for ductal carcinoma in situ of the breast. Conn Med 54 (1990) 482-484
83. Kurtz J.M., Jacquemier J., Torhorst J., et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63 (1989) 1630-1635
84. Ray G.R., Adelson J., Hayhurst E., et al. Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 28 (1993) 105-111
85. Fourquet A., Zafrani B., Campana F., et al. Breast-conserving treatment of ductal carcinoma in situ. Semin Radiat Oncol 2 (1992) 116-124
86. Silverstein M.J., Barth A., Poller D.N., et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31A (1995) 1425-1427
87. Solin L.J., Fourquet A., McCormick B., et al. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys 30 (1994) 3-9
88. Silverstein M.J., Lagios M.D., Martino S., et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 16 (1998) 1367-1373
89. Lagios M.D. Duct carcinoma in situ: biological implications for clinical practice. Semin Oncol 23 (1996) 6-11
90. Arthur D.W., and Vicini F.A. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 23 (2005) 1726-1735
91. Keisch M., Vicini F.A., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
92. Vicini F.A., Kestin L., Chen P., et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95 (2003) 1205-1210
93. Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 (2003) 1247-1253
94. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet 362 (2003) 95-102
95. Lagios M.D. Lagios experience. In: Silverstein M.J. (Ed). Ductal Carcinoma in- situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 363-364
96. Arnesson L.G., and Olsen K. Linkoping experience. In: Silverstein M.J. (Ed). Ductal Carcinoma in-situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 373-378
97. Baird R.M., Worth A., and Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg 159 (1990) 479-481
98. Cataliotti L., Distante V., and Pacini P. In: Silverstein M.J. (Ed). Ductal Carcinoma in situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 449-454
99. Salvadori B., Delledonne V., and Rovini D. National Cancer Institute-Milan experience. In: Silverstein M.J. (Ed). Ductal Carcinoma in-situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 427-432
100. Shreer I. Conservation therapy of DCIS without radiation. Breast Disease 9 (1996) 27-36
101. Schwartz G.F., Finkel G.C., Garcia J.C., et al. Subclinical ductal carcinoma of the breast: treatment by local excision and surveillance alone. Cancer 70 (1992) 2468-2474
102. Schwartz G.F. Treatment of subclinical ductal carcinoma in situ by excision and local surveillance. In: Silverstein M.J. (Ed). Ductal Carcinoma in-situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 353-360
103. Silverstein M.J., Lagios M.D., Craig P.H., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 77 (1996) 2267-2274
104. Schnitt S.J., Harris J.R., and Smith B.L. Developing a prognostic index for ductal carcinoma in situ of the breast: are we there yet?. Cancer 77 (1996) 2189
105. de Mascarel I., Bonichon F., MacGrogan G., et al. Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: fractional considerations. Breast Cancer Res Treat 61 (2000) 151-159
106. Boland G.P., Chan K.C., Know W.F., et al. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg 90 (2003) 426-432
107. Silverstein M. The University of Southern California Van Nuys Prognostic Index. In: Wilkins L.W. (Ed). Ductal Carcinoma in- situ of the Breast. 2nd edition (2002), Lippincott Williams & Wilkins, Philadelphia, PA 459
108. Silverstein M.J., Lagios M.D., Groshen S., et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 40 (1999) 1455-1461
109. Wong J., Gadd M., Gelman R., et al. Wide excision alone for ductal carcinoma in situ (DCIS) of the breast. Proc Am Soc Clin Oncol (2003) 22
110. Rampaul R., Valasiadou P., Pinder S., et al. Wide local excision with 10 mm clearance without radiotherapy for DCIS. Eur J Surg Oncol 27 (2001) 788
111. Dershaw D.D. Mammography in patients with breast cancer treated by breast conservation (lumpectomy with or without radiation). AJR 164 (1995) 309-316
112. Hassell P.R., Olivotto I.A., Mueller H.A., et al. Early breast cancer: detection of recurrence after conservative surgery and radiation therapy. Radiology 176 (1990) 731-735
113. Mendelson E.B. Evaluation of the postoperative breast. Radiol Clin North Am 30 (1992) 107-138
114. Orel S.G., Troupin R.H., Patterson E.A., et al. Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection. Radiology 183 (1992) 201-206
115. Orel S.G., Fowble B.L., Solin L.J., et al. Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: prognostic significance of detection method. Radiology 188 (1993) 189-194
116. Ashikari R., Huvos A.G., and Snyder R.E. Prospective study of non-infiltrating carcinoma of the breast. Cancer 39 (1977) 435-439
117. Sunshine J.A., Moseley M.S., Fletcher W.S., et al. Breast carcinoma in situ: a retrospective review of 112 cases with a minimum 10-year follow-up. Am J Surg 150 (1985) 44-51
118. Farrow J.H. Current concepts in the detection and the treatment of the earliest of the early breast cancers. Cancer 25 (1970) 468-477
119. Silverstein M.J., Cohlan B.F., Gierson E.D., et al. Duct carcinoma in situ: 228 cases without microinvasion. Eur J Cancer 28 (1992) 630-634
120. Von Rueden D.G., and Wilson R.E. Intraductal carcinoma of the breast. Surg Gynecol Obstet 158 (1984) 105-111
121. Schuh M.E., Nemoto T., Penetrante R., et al. Intraductal carcinoma: analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 121 (1986) 1303-1307
122. Arnesson L.G., Smeds S., Fagerberg G., et al. Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 76 (1989) 672-675
123. Solin L.J., Fowble B.L., Schultz D.J., et al. Definitive irradiation for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 19 (1990) 843-850
124. Amichetti M., Caffo O., Richetti A., et al. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. Eur J Cancer 33 (1997) 1559-1565
125. Beron P., Lewinsky B.S., and Silverstein M.J. Van Nuys experience with excision plus radiation therapy. In: Silverstein M.J. (Ed). Ductal Carcinoma in-situ of the Breast (1997), Williams and Wilkins, Baltimore, MD 405-409
126. Mirza N.Q., Vlastos G., Meric F., et al. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy. Ann Surg Oncol 7 (2000) 656-664
127. Carpenter R., Boulter P.S., Cooke T., et al. Management of screen-detected ductal carcinoma in situ of the female breast. Br J Surg 76 (1981) 564-567
128. Eusebi V., Feudale E., Foschini M.P., et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11 (1994) 223-235
129. Sibbering D.M., and Blamey R.W. Nottingham experience. In: Silverstein M.J. (Ed). Ductal Carcinoma in-situ of the Breast 36 (1997), Williams and Wilkins, Baltimore, MD 367-372